
Pediatrix Medical Group, Inc.
MDNYSECIK 893949HealthcareFiscal year ends Dec 31
Reports and events: 259 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-03-0817:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-006748 |
| 2023-02-1707:00 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-003127 |
| 2023-02-1706:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-003125 |
| 2023-01-2017:24 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-23-000157 |
| 2022-12-1607:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-026632 |
| 2022-12-0217:25 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-22-003156 |
| 2022-11-0307:00 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-021526 |
| 2022-11-0306:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-021516 |
| 2022-09-2316:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-250187 |
| 2022-08-0407:22 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-014473 |
| 2022-08-0407:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-014467 |
| 2022-06-2107:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-011839 |
| 2022-05-1717:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000950170-22-010201 |
| 2022-04-2807:00 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-006427 |
| 2022-04-2806:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-006426 |
| 2022-04-0117:00 ET | DEF 14A | Proxy statementPeriod 2022-05-12 | 0001193125-22-093819 |
| 2022-02-2517:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-22-002114 |
| 2022-02-1707:02 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-001387 |
| 2022-02-1706:52 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-001386 |
| 2022-02-1407:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-001148 |
| 2021-11-1917:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-21-004821 |
| 2021-10-2807:01 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000950170-21-002406 |
| 2021-10-2806:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-21-002405 |
| 2021-08-3107:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001193805-21-001252 |
| 2021-08-2716:31 ET | 8-K | 8.01 Other events | 0000950170-21-001577 |
| 2021-08-0607:05 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0000950170-21-000978 |
| 2021-08-0606:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-238355 |
| 2021-05-1716:24 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-21-163735 |
| 2021-05-1416:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-21-161991 |
| 2021-05-0707:00 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001193125-21-154019 |
| 2021-05-0706:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-154005 |
| 2021-03-2316:18 ET | DEF 14A | Proxy statementPeriod 2021-05-12 | 0001193125-21-091206 |
| 2021-02-1807:00 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001193125-21-047064 |
| 2021-02-1806:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-047053 |
| 2020-12-2116:25 ET | 8-K | 2.01 Completion of an acquisition or disposition; 2.04 Item not in the standard list; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-323140 |
| 2020-11-2416:17 ET | 8-K | 8.01 Other events | 0001193125-20-302610 |
| 2020-11-0607:01 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001193125-20-287356 |
| 2020-11-0606:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-287348 |
| 2020-09-2917:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-20-257929 |
| 2020-09-1521:11 ET | 8-K | 1.01 Entry into a material agreement; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-20-245502 |
| 2020-09-1006:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-242587 |
| 2020-08-2506:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-229109 |
| 2020-07-3007:00 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001193125-20-203325 |
| 2020-07-3006:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-203317 |
| 2020-07-2816:18 ET | DEF 14A | Proxy statementPeriod 2020-09-09 | 0001193125-20-200999 |
| 2020-07-1317:25 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-20-001971 |
| 2020-07-1309:10 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-191602 |
| 2020-06-1521:27 ET | 8-K | 8.01 Other events | 0001193125-20-168098 |
| 2020-06-0506:50 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-161340 |
| 2020-05-1509:00 ET | SC 13D/A | Ownership report, active investor, amended | 0001193805-20-000593 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:14 ET. Listed shows no prices and gives no investment advice.